His595Tyr Polymorphism in the Methionine Synthase Reductase (MTRR) Gene Is Associated With Pancreatic Cancer Risk

Gastroenterology

Volumn 135, Issue 2, 2008, Pages

  Ohnami, Shumpei ^a   Sato, Yasunori ^a   Yoshimura, Kimio ^a   Ohnami, Sumiko ^a   Sakamoto, Hiromi ^a   Aoki, Kazunori ^a   Ueno, Hideki ^b   Ikeda, Masafumi ^b   Morizane, Chigusa ^b   Shimada, Kazuaki ^b   Sakamoto, Yoshihiro ^b   Esaki, Minoru ^b   Saito, Ikuo ^c   Hirose, Hiroshi ^c   Saito, Daizo ^b   Sugimura, Haruhiko ^d   Kosuge, Tomoo ^b   Okusaka, Takuji ^b   Yoshida, Teruhiko ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; METHIONINE SYNTHASE REDUCTASE;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; EMBRYO; FEMALE; FISHER EXACT TEST; GENE; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METHIONINE SYNTHASE REDUCTASE GENE; METHYLATION; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 48549101661     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.04.016     Document Type: Article

References (43)

1. Rosewicz S., and Wiedenmann B. Pancreatic carcinoma. Lancet 349 (1997) 485-489
2. Honda K., Hayashida Y., Umaki T., et al. Possible detection of pancreatic cancer by plasma protein profiling. Cancer Res 65 (2005) 10613-10622
3. Lynch H.T., Smyrk T., Kern S.E., et al. Familial pancreatic cancer: a review. Semin Oncol 23 (1996) 251-275
4. Gullo L., Pezzilli R., Morselli-Labate A.M., and Italian Pancreatic Cancer Study Group. Diabetes and the risk of pancreatic cancer. N Engl J Med 331 (1994) 81-84
5. Lowenfels A.B., and Maisonneuve P. Pancreatic cancer: development of a unifying etiologic concept. Ann N Y Acad Sci 880 (1999) 191-200
6. Berrington de G.A., Sweetland S., and Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 89 (2003) 519-523
7. Soliman A.S., Bondy M., Webb C.R., et al. Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients. Int J Cancer 119 (2006) 1455-1461
8. Qiu D., Kurosawa M., Lin Y., et al. Overview of the epidemiology of pancreatic cancer focusing on the JACC Study. J Epidemiol 15 (2005) S157-S167
9. World Cancer Research Fund. Food, nutrition, and the prevention of cancer: a global perspective (1997), American Institute of Cancer Research, Washington DC
10. Stolzenberg-Solomon R.Z., Pietinen P., Barrett M.J., et al. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am J Epidemiol 153 (2001) 680-687
11. Vineis P., Malats N., Lang M., et al. Metabolic polymorphisms and susceptibility to cancer (1999), International Agency for Research on Cancer, Lyon (France) IARC Sci Publ No. 148
12. Li D., Frazier M., Evans D.B., et al. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. J Clin Oncol 24 (2006) 1720-1728
13. Jiao L., Bondy M.L., Hassan M.M., et al. Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. Cancer 109 (2007) 840-848
14. Duell E.J., Casella D.P., Burk R.D., et al. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 15 (2006) 726-731
15. Verlaan M., Drenth J.P., Truninger K., et al. Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases. J Med Genet 42 (2005) e62
16. Ockenga J., Vogel A., Teich N., et al. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 124 (2003) 1802-1808
17. Li D., Ahmed M., Li Y., et al. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1470-1476
18. Li D., Jiao L., Li Y., et al. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27 (2006) 103-111
19. Duell E.J., Holly E.A., Bracci P.M., et al. A population-based study of the Arg399Gln polymorphism in x-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res 62 (2002) 4630-4636
20. Yoshimura K., Hanaoka T., Ohnami S., et al. Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples. J Hum Genet 48 (2003) 654-658
21. Skol A.D., Scott L.J., Abecasis G.R., et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38 (2006) 209-213
22. Satagopan J.M., Verbel D.A., Venkatraman E.S., et al. Two-stage designs for gene-disease association studies. Biometrics 58 (2002) 163-170
23. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6 (2005) 95-108
24. Fallin D., and Schork N.J. Acuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 67 (2000) 947-959
25. Gabriel S.B., Schaffner S.F., Nguyen H., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
26. Schaid D.J., Rowland C.M., Tines D.E., et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
27. Leclerc D., Wilson A., Dumas R., et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci U S A 95 (1998) 3059-3064
28. Zhang W., Braun A., Bauman Z., et al. Expression profiling of homocysteine junction enzymes in the NCI60 panel of human cancer cell lines. Cancer Res 65 (2005) 1554-1560
29. Pfeiffer C.M., Twite D., Shih J., et al. Method comparison for total plasma homocysteine between the Abbott IMx analyzer and an HPLC assay with internal standardization. Clin Chem 45 (1999) 152-153
30. Chalitchagrn K., Shuangshoti S., Hourpai N., et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23 (2004) 8841-8846
31. Sharp L., and Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 159 (2004) 423-443
32. Yamada K., Gravel R.A., Toraya T., et al. Human methionine synthase reductase is a molecular chaperone for human methionine synthase. Proc Natl Acad Sci U S A 103 (2006) 9476-9481
33. Zavadakova P., Fowler B., Suormala T., et al. cblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression. Hum Mutat 25 (2005) 239-247
34. Gaughan D.J., Kluijtmans L.A., Barbaux S., et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157 (2001) 451-456
35. Otani T., Iwasaki M., Hanaoka T., et al. Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr Cancer 53 (2005) 42-50
36. Larsson S.C., Hakansson N., Giovannucci E., et al. Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst 98 (2006) 407-413
37. Wei E.K., Giovannucci E., Selhub J., et al. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst 97 (2005) 684-692
38. Zhang S.M., Willett W.C., Selhub J., et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 95 (2003) 373-380
39. Hoover K.L., and Poirier L.A. Hepatocyte-like cells within the pancreas of rats fed methyl-deficient diets. J Nutr 116 (1986) 1569-1575
40. Nygard O., Refsum H., Ueland P.M., et al. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 67 (1998) 263-270
41. Nishigaki M., Aoyagi K., Danjoh I., et al. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. Cancer Res 65 (2005) 2115-2124
42. Sato N., Maitra A., Fukushima N., et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 63 (2003) 4158-4166
43. Schernhammer E., Wolpin B., Rifai N., et al. Plasma folate, vitamin B-6, vitamin B-12, and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res 67 (2007) 5553-5560